The history of Sildenafil presents a interesting case for stakeholders in the pharmaceutical sector. While initially a phenomenal success, creating vast sums, the exclusivity end and the subsequent flood of off-brand https://escort300332.prublogger.com/40601738/the-little-copyright-and-big-pharma-a-risky-bet